MetaCap

Dogwood Therapeutics (DWTX) vs Stablecoin Development (SDEV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Dogwood Therapeutics (DWTX) has outperformed Stablecoin Development (SDEV) over the past year, losing 83.7% versus a loss of 88.4%. Over five years, DWTX leads with a -99.2% price change compared with -100.0% for SDEV. Dogwood Therapeutics is the larger company by market cap ($39.6 million vs $36.9 million), about 1.1 times the size.

On valuation, Dogwood Therapeutics trades at a lower trailing P/E (0.1x vs 0.2x for Stablecoin Development).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DWTX-83.68%SDEV-88.37%
+2239%+1020%-199%
Nov 21, 20251 yearNov 20, 2026
DWTX-99.25%SDEV-99.98%
+67%-21%-108%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DWTX versus SDEV key metrics
MetricDWTXSDEV
Share price$1.04$0.50
Market cap$39.57M$36.90M
1-day change-2.36%-10.30%
YTD return-75.12%-98.23%
1-year return-83.68%-88.37%
5-year return-99.16%-99.98%
P/E ratio (TTM)0.100.19
EPS (TTM)$10.26$2.70
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-34.26M$-630.78M
52-week high$7.04$99.75
52-week low$0.901$0.467
Distance from 52-week high-85.31%-99.50%
Analyst consensusnone—
Avg. price target upside+1252.66%—
Average volume89.88K16.98M
Shares outstanding38.23M73.80M
Employees82
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Stablecoin Development trades at a higher earnings multiple (0.2x vs 0.1x trailing P/E).

About Dogwood Therapeutics

DWTX stock →

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for acute surgical pain; and IMC-2, a combination of valacyclovir and celecoxib intended to synergistically suppress herpesvirus activation; and Serpin Peptide 16 that is in early Phase 1 development to reduce neuropathy secondary to treat chemotherapeutic agents that are neurotoxic.

Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees

About Stablecoin Development

SDEV stock →

Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.

Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees

DWTX vs SDEV FAQ

Which is bigger, Dogwood Therapeutics or Stablecoin Development?

Dogwood Therapeutics (DWTX) is larger, with a market capitalization of $39.57M compared with $36.90M for Stablecoin Development (SDEV).

Which stock has performed better over the past year, DWTX or SDEV?

DWTX returned -83.68% over the past 12 months, compared with -88.37% for SDEV (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, DWTX or SDEV?

DWTX has the lower trailing P/E at 0.1, versus 0.2 for SDEV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Dogwood Therapeutics and Stablecoin Development in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons